LGND financials
Ligand Pharmaceuticals (LGND) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
LGND income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $268.09M | $261.50M | $47.20M | $124.45M | 6.13 |
| 2024 | $167.13M | $156.06M | -$22.61M | -$4.03M | -0.22 |
| 2023 | $131.31M | $96.27M | $11.94M | $52.15M | 2.94 |
| 2022 | $196.25M | $143.42M | $3.04M | -$33.36M | -1.98 |
| 2021 | $241.54M | $179.37M | $103.85M | $57.14M | 3.34 |
| 2020 | $163.56M | $133.14M | $37.50M | -$2.98M | -0.18 |
- LGND revenue was $268.09M in fiscal 2025, net income $124.45M.
Updated 2026-11-02 23:13 UTC